CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.09
+3.96%Year over year
Reported trailing growth
- Revenue
- +32.5%
- EBITDA
- -29.0%
- EBIT
- -41.3%
- EPS
- -44.0%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +17.9%
- EBITDA
- +34.3%
- EPS
- +22.3%
Three-year CAGR
- Revenue
- +21.6%
- EBITDA
- -22.6%
- EBIT
- -22.4%
- Net income
- -35.0%
- EPS
- -28.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026